eGene Overview
- Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
eGene General Information
Description
Developer of bio-separation and detection tools intended for research in life sciences, applied testing and molecular diagnostics. The company specializes in electrophoresis, microfluidics, liquid handling and automation genotyping DNA testing tools for the biological, microbial materials and life sciences testing industries, helping its clients in detecting, quantifying, and identifying biological organisms and automating routine and non-routine laboratory and industrial procedures critical to productivity.
Contact Information
Formerly Known As
BioCal Technology
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Acquirer
Primary Office
- 17841 Fitch
- Irvine, CA 92614
- United States
eGene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
eGene Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
eGene Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 14-Jul-2004 | 0000000000 | Special Purpose Acquisition Company (SPAC) | 000 00000 |